From Bench to Bedside – Integrated Preclinical and Clinical Development

AKROS Bioscience supports universities, biotech companies and innovators in translating promising scientific concepts into structured development programmes.

Through two highly qualified and complementary teams covering preclinical and clinical development, we design integrated development plans that define the most appropriate pathway from early proof of concept to clinical investigation.

Our support includes the identification and planning of the required preclinical studies, the definition of translational milestones and development decision points, and the design of the clinical development strategy, up to and including First-in-Human studies.

By combining scientific, medical, regulatory and methodological expertise, we help our partners build a coherent and efficient development roadmap, anticipate potential criticalities and generate the evidence required to progressively move an innovative product from the bench to the bedside.